-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

637A.O2.6 637. Myelodysplastic Syndromes – Clinical and Epidemiological: Treatment Options and Decision Making in Low Risk MDS

Symposia: Myelodysplastic Syndromes – Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
adult, Research, clinical trials, Clinical Practice (Health Services and Quality), epidemiology, Clinical Research, health outcomes research, drug development, Diseases, Therapies, real-world evidence, Adverse Events, Myeloid Malignancies, Study Population, Human
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Pacific Ballroom Salons 18-19 (Marriott Marquis San Diego Marina)
Moderators:
Yasmin Abaza, MD, The University of Texas MD Anderson Cancer Center and Namrata Sonia Chandhok, MD, Yale New Haven Hospital
Disclosures:
No relevant conflicts of interest to declare.
This session has several later phase clinical trials. It is more focused on lower risk MDS
2:00 PM

Guillermo Garcia-Manero, MD1, Uwe Platzbecker, MD2, Valeria Santini, MD3*, Amer M. Zeidan, MBBS, MHS4, Pierre Fenaux, MD, PhD5, Rami S. Komrokji, MD6, Jake Shortt7*, David Valcarcel8*, Anna Jonasova9*, Sophie Dimicoli-Salazar10*, Ing Soo Tiong11*, Chien-Chin Lin, MD, PhD12*, Jiahui Li, PharmD13, Jennie Zhang13*, Ana Carolina Giuseppi13*, Sandra Kreitz14*, Veronika Pozharskaya13*, Karen L. Keeperman13*, Shelonitda Rose13*, Thomas Prebet13*, Andrius Degulys15,16*, Stefania Paolini17*, Thomas Cluzeau, M.D.18* and Matteo Giovanni Della Porta, MD19,20*

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Hematology, Cellular Therapy, Hemostaseology and Infectious Diseases, University Leipzig Medical Center, Leipzig, Germany
3MDS Unit, DMSC, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Florence, Italy
4Department of Internal Medicine, Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
5Hôpital Saint-Louis, Université Paris 7, Paris, France
6Moffitt Cancer Center, Tampa, FL
7Monash University and Monash Health, Melbourne, VIC, Australia
8Hospital Universitari Vall d'Hebron, Barcelona, Spain
9Medical Department Hematology, Charles University General University Hospital, Prague, Czech Republic
10Hôpital Haut-Lévêque, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France
11Malignant Haematology & Stem Cell Transplantation, The Alfred, Melbourne, VIC, Australia
12Department of Laboratory Medicine, National Taiwan University Hospital, Taipei, Taiwan
13Bristol Myers Squibb, Princeton, NJ
14Celgene International Sàrl, a Bristol-Myers Squibb Company, Boudry, Switzerland
15Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
16Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania
17IRCCS Azienda Ospedaliero-Universitaria di Bologna - Istituto di Ematologia “Seràgnoli”, Bologna, Italy
18Département d'Hématologie Clinique, Université Cote d'Azur, CHU Nice, Nice, France
19Cancer Center IRCCS Humanitas Research Hospital, Milan, Italy
20Department of Biomedical Sciences, Humanitas University, Milan, Italy

2:15 PM

Rami S. Komrokji, MD1, Valeria Santini, MD2*, Pierre Fenaux, MD, PhD3, Michael R. Savona, MD4*, Yazan F. Madanat, MD5, Tymara Berry, MD6*, Laurie Sherman, BSN6, Shyamala Navada, MD6*, Faye M. Feller, MD6, Libo Sun, PhD6*, Qi Xia, PhD6*, Ying Wan, MD, PhD6*, Fei Huang, PhD6, Amer M. Zeidan, MBBS, MHS7 and Uwe Platzbecker, MD8

1Moffitt Cancer Center, Tampa, FL
2MDS UNIT, DMSC, Azienda Ospedaliero-Universitaria Careggi & University of Florence, Florence, Italy
3Hôpital Saint-Louis, Université Paris 7, Paris, France
4Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
5Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
6Geron Corporation, Parsippany, NJ
7Yale School of Medicine and Yale Cancer Center, Yale University, New Haven, CT
8Cellular Therapy and Hemostaseology, Leipzig University Hospital, Leipzig, Germany

2:30 PM

Moshe Mittelman, MD1, David H. Henry2, John Glaspy3*, Anil Tombak4*, Rosemary Anne Harrup5*, Krzysztof Madry, MD, PhD6*, Barbara Grabowska7*, Uwe Platzbecker, MD8, Tyson Lee9* and Katharina Modelska9*

1Tel-Aviv Sourasky Medical Center, Tel-Aviv University, Tel-Aviv, Israel
2Hospitals of the University of Pennsylvania‒Penn Presbyterian, Philadelphia
3University of California‒Los Angeles, Los Angeles
4Mersin University Medical Faculty, Mersin, Turkey
5Royal Hobart Hospital, Tasmania, Australia
6Medical University of Warsaw, Warsaw, Poland
7Centrum Medyczne PROMED, Krakow, Poland
8University Hospital of Leipzig, Leipzig, Germany
9FibroGen, Inc., San Francisco, CA

2:45 PM

Maria Diez-Campelo, MD, PhD1*, David M. Ross, MBBS, PhD, FRACP, FRCPA2*, Aristoteles Giagounidis3, Shuhying Tan, FRACP, FRCPA, MBBS4*, Thomas Cluzeau, MD, PhD5, Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA6, David Valcarcel, MD, PhD7, Montserrat Arnan, MD, PhD8*, Christine Graham, PhD9*, Allie McGinty9*, Miranda Ross, BS9*, Wei Feng9*, Ying Jiang9*, Suresh Bobba9*, Montagu Hankin, MSc9*, Christopher Rovaldi9*, Dena Grayson, MD, PhD9*, Simon Cooper, MBBS9 and Jen L. Salstrom, MD, PhD9

1Universidad de Salamanca, Salamanca, Spain
2Department of Haematology, Flinders Medical Centre and University, Adelaide, SA, Australia
3Dept. Oncology, Hematology and Palliative Care, Marienhospital Düsseldorf, Düsseldorf, Germany
4St. Vincent's Institute of Medical Research, East Melbourne, Vic, AUS
5Nice University Hospital, Nice, Provence Alpes Cote d'Azur, France
6Department of Clinical Haematology and Bone Marrow Transplant Service, The Royal Melbourne Hospital, Parkville, Australia
7Department of Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Barcelona, Spain
8Institut Català d’Oncologia , Hospital Duran i Reynals, Barcelona, Spain
9Keros Therapeutics, Lexington, MA

3:00 PM

Cristina Astrid Tentori, MD1*, Caterina Gregorio, PhD2*, Marie Robin, MD3*, Nico Gagelmann4*, Carmelo Gurnari, MD5, Somedeb Ball, MD6, Juan Carlos Caballero Berrocal, MD7*, Luca Lanino, MD8, Saverio D'Amico, MSc1*, Marta Spreafico, PhD2*, Giulia Maggioni, MD1*, Erica Travaglino, BS1*, Elisabetta Sauta, PhD1*, Manja Meggendorfer, PhD9, Lin-Pierre Zhao, MD10*, Massimo Bernardi, MD11*, Carmen Di Grazia, MD12*, Luca Vago, MD, PhD13, Giulia Rivoli, MD14*, Lorenza Maria Borin, MD15*, Patrizia Chiusolo16*, Luisa Giaccone, MD, PhD17*, Maria Teresa Voso, MD18, Jan Philipp Bewersdorf, MD19, Olivier Nibourel, PhD20*, Marina Díaz-Beyá, MD, PhD21*, Andres Jerez, MD22*, Francisca Maria Hernandez, MD23*, Kyra Velázquez Kennedy, MD24*, Blanca Xicoy, MD25*, Marta Ubezio, MD1*, Alessia Campagna1*, Antonio Russo, MD1*, Gabriele Todisco, MD1*, Daniele Mannina, MD1*, Stefania Bramanti1*, Matteo Zampini, PhD1*, Elena Riva, BSc1*, Marilena Bicchieri, PhD1*, Gianluca Asti, MSc1*, Filippo Viviani, MD1*, Alessandro Buizza, MD1*, Benedetta Tinterri, MD1*, Andrea Bacigalupo, MD26, Alessandro Rambaldi, M.D.27, Francesco Passamonti, MD28*, Fabio Ciceri29*, Victor Savevski, MEng1*, Armando Santoro, MD30*, Najla H Al Ali, MS31*, David A Sallman, MD32, Francesc Sole, PhD33, Guillermo Garcia-Manero, MD34, Ulrich Germing35*, Shahram Kordasti, MD, PhD36, Valeria Santini, MD37, Guillermo Sanz, MD, PhD38*, Wolfgang Kern, MD9, Anne Sophie Kubasch, MD39*, Uwe Platzbecker, MD40, Maria Diez-Campelo, MD, PhD41*, Jaroslaw P. Maciejewski, M.D., Ph.D., FACP5, Lionel Ades, MD, PhD42, Pierre Fenaux, MD, PhD43, Torsten Haferlach, MD, PhD9, Amer M. Zeidan, MBBS, MHS44, Gastone Castellani, PhD45*, Rami S. Komrokji, MD31, Francesca Ieva, PhD2* and Matteo Giovanni Della Porta, MD1*

1Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy
2Politecnico di Milano, Milano, Italy
3Hopital Saint-Louis, Paris, France
4University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Hamburg, DEU
5Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
6Vanderbilt University Medical Center, Nashville, TN
7Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain, Salamanca, ESP
8Humanitas Clinical and Research Center, IRCCS, Rozzano, Milano, Italy
9MLL Munich Leukemia Laboratory, Munich, Germany
10Department of Hematology and Bone Marrow Transplantation, Hôpital Saint-Louis/Assistance Publique-Hôpitaux de Paris (AP-HP)/University Paris 7, Paris, France, Paris, FRA
11Unit of Hematology and Bone Marrow Transplantation, I.R.C.C.S. Ospedale San Raffaele, Milan, Italy
12Hematology and Transplant Center, IRCCS Ospedale Policlinico San Martino, Genua, Italy, Genova, Italy
13Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. Ospedale San Raffaele, Milano, NA, Italy
14Hematology and Cellular Therapy Division, IRCCS Ospedale Policlinico San Martino, Genova, Genova, Italy
15Hematology, Ospedale San Gerardo, Monza, Italy, Monza, Italy
16Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma, Italy
17Univesity of Torino, AOU Città Della Salute E Della Scienza Di Torino,, Torino, ITA
18Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
19Department of Medicine, Section of Hematology, Yale University, New Haven, CT
20Laboratory of Hematology, CHU Lille, Lille, France, Paris, FRA
21Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain
22Cleveland Clinic Taussig Cancer Institute, Cleveland, OH
23Department of Hematology, Hospital Virgen de las Nieves, Granada, Spain
24Department of Hematology, Ramón y Cajal University Hospital – IRYCIS, Madrid, Spain, Madrid, Spain
25Hematology Department, Institut Català d’Oncologia, Hospital Universitari Germans Trias i Pujol, Institut de Recerca Contra la Leucèmia Josep Carreras, Universitat Autònoma de Barcelona, Badalona, Barcelona, Spain
26Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
27Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo BG, Italy
28Dipartimento di Oncologia ed Ematologia, Università degli Studi di Milano, Policlinico di Milano, Ospedale Maggiore, Fondazione I.R.C.C.S. Ca Granda, Milano, Italy
29Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy
30Humanitas Cancer Center, Rozzano, Mi, Italy
31Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
32H. Lee Moffitt Cancer Center, Tampa, FL
33Myelodysplastic Syndromes Research Group, Josep Carreras Leukaemia Research Institute, ICO-Hospital Germans Trias i Pujol, Universitat Autònoma de Barcelona, Badalona, Spain
34University of Texas MD Anderson Cancer Center, Houston, TX
35Department of Hematology, Oncology and Clinical Immunology, Universitatsklinik Dusseldorf, Dusseldorf, Germany
36King's College London, London, United Kingdom
37MDS Unit, DMSC, AOU Careggi, University of Florence, Firenze, Italy
38Health Research Institute La Fe, Valencia, Spain, Valencia, Spain
39Department of Hematology, University Hospital of Leipzig, Dresden, Germany
40University Leipzig Medical Center, Leipzig, Germany
41University Hospital of Salamanca, Salamanca, Spain
42Saint Louis Hospital, APHP, Paris, France
43Department of Hematology, Université de Paris, Saint-Louis Hospital, Paris, France
44Section of Hematology, Department of Internal Medicine, Yale University School of Medicine - Yale Cancer Center, New Haven, CT
45Department of Physics and Astronomy (DIFA), Bologna, Italy., Bologna, Italy

3:15 PM

Sandra Huber, PhD*, Natalie Wossidlo, PhD*, Torsten Haferlach, MD, PhD, Manja Meggendorfer, PhD, Stephan Hutter, PhD*, Gregor Hoermann, MD, PhD, Isolde Summerer*, Henning Ruge, PhD*, Constance Regina Baer, PhD, Wolfgang Kern, MD and Claudia Haferlach, MD

MLL Munich Leukemia Laboratory, Munich, Germany

*signifies non-member of ASH